Drug Enforcement D-0178-2024

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Status

Terminated

Classification

Class II

Report Date

January 3, 2024

Termination Date

September 29, 2024

Product Information

Product description
Doxycycline Capsules, USP 100 mg, 50 Capsules, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 Unite States; Manufactured by: Lupin Limited, Nagpur - 441 108, INDIA. NDC 68180-652-08
Product quantity
1 unit
Reason for recall
CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Nationwide USA

Location & Firm

Recalling firm
CARDINAL HEALTHCARE
Address
7200 Cardinal Pl W

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0178-2024
Event ID
89450
Recall initiation date
January 26, 2022
Center classification date
December 26, 2023
Code info
Batch G104819
More code info
—